Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase NA 1Phase 3 1Phase 2/3 1

Status

Unknown 3Terminated 1Completed 1

Sponsor Class

OTHER 405INDUSTRY 154NIH 92NETWORK 9OTHER_GOV 5UNKNOWN 2

Study Type

Interventional 5

Sponsor

Cancer Type

Gastrointestinal 3Thoracic 1Head & Neck 1

Conditions

Carcinoma, Hepatocellular 3Thyroid Neoplasms 1Small Cell Lung Carcinoma 1Neoplasms 1Liver Neoplasms 1Carcinoma 1

Interventions

Cisplatin 50Capecitabine 42apatinib 34Radiotherapy 33Oxaliplatin 33Gemcitabine 33Cyclophosphamide 32Drug Therapy 31Paclitaxel 30Carboplatin 29tislelizumab 27Irinotecan 27Fluorouracil 26Docetaxel 26Bevacizumab 23Surgical Procedures, Operative 21Nivolumab 19pembrolizumab 18fludarabine 18Radiation 16Metformin 16Exercise 16camrelizumab 15S 1 (combination) 14Control Groups 14Blood Specimen Collection 14Pemetrexed 13Standard of Care 12anlotinib 11Neoadjuvant Therapy 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
OTHER_GOV × Sorafenib × Clear all
NCT05391867 2022-05-26

Assessment of the Efficacy of Lenvatinib Versus Sorafenib in the Management of Advanced Hepatocellular Carcinoma

Sir Salimullah Medical College Mitford Hospital

Phase NA Unknown
70 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT02794337 2022-04-27

TACE-SBRT

Tata Memorial Hospital

Phase 2/3 Unknown
67 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT02084732 2019-11-13

Safety and Efficacy of Sorafenib in Patients With Advanced Thyroid Cancer: a Phase II Clinical Study

Instituto Nacional de Cancerologia, Columbia

Phase 2 Completed
35 enrolled
Head & Neck

Thyroid Neoplasms

NCT01159327 2015-11-11

Study of Sorafenib Maintenance in Patients With ED-SCLC After Response to Induction Chemotherapy

National Cancer Center, Korea

Phase 2 Terminated
13 enrolled
Thoracic

Small Cell Lung Carcinoma

NCT01214343 2011-06-15

Comparing Efficacy of Sorafenib Versus Sorafenib in Combination With Low-dose FP in Patients With Advanced HCC

Ministry of Health, Labour and Welfare, Japan

Phase 3 Unknown
190 enrolled
Gastrointestinal

Carcinoma, Carcinoma, Hepatocellular, Liver Neoplasms, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡